Common Contracts
7 similar Agreement and Plan of Merger contracts by Alpine Immune Sciences, Inc., AveXis, Inc., Celator Pharmaceuticals Inc, others
AGREEMENT AND PLAN OF MERGER DATED AS OF APRIL 10, 2024, AMONG VERTEX PHARMACEUTICALS INCORPORATED, ADAMS MERGER SUB, INC. AND ALPINE IMMUNE SCIENCES, INC.Agreement and Plan of Merger • April 10th, 2024 • Alpine Immune Sciences, Inc. • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER, dated as of April 10, 2024 (this “Agreement” and, such date, the “Agreement Date”), by and among Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (“Parent”), Adams Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and Alpine Immune Sciences, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER DATED AS OF JUNE 18, 2023, AMONG ELI LILLY AND COMPANY, DURNING ACQUISITION CORPORATION AND DICE THERAPEUTICS, INC.Agreement and Plan of Merger • June 20th, 2023 • DICE Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER, dated as of June 18, 2023 (this “Agreement” and, such date, the “Agreement Date”), by and among Eli Lilly and Company, an Indiana corporation (“Parent”), Durning Acquisition Corporation, a Delaware corporation and a direct or indirect wholly owned subsidiary of Parent (“Merger Sub”), and DICE Therapeutics, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER dated as of April 6, 2018, among NOVARTIS AG, NOVARTIS AM MERGER CORPORATION and AVEXIS, INC.Agreement and Plan of Merger • April 9th, 2018 • AveXis, Inc. • Biological products, (no disgnostic substances) • Delaware
AGREEMENT AND PLAN OF MERGER dated as of April 6, 2018 (this “Agreement”), among Novartis AG, a company organized under the laws of Switzerland (“Parent”), Novartis AM Merger Corporation, a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Parent, and AveXis, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER dated as of May 27, 2016, among JAZZ PHARMACEUTICALS PLC, PLEX MERGER SUB, INC. and CELATOR PHARMACEUTICALS, INC.Agreement and Plan of Merger • May 31st, 2016 • Celator Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER dated as of May 27, 2016 (this “Agreement”), among JAZZ PHARMACEUTICALS PLC, an Irish public limited company (“Parent”), PLEX MERGER SUB, INC., a Delaware corporation (“Merger Sub”) and an indirect wholly owned subsidiary of Parent, and Celator Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER dated as of May 27, 2016, among JAZZ PHARMACEUTICALS PLC, PLEX MERGER SUB, INC. and CELATOR PHARMACEUTICALS, INC.Agreement and Plan of Merger • May 31st, 2016 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER dated as of May 27, 2016 (this “Agreement”), among JAZZ PHARMACEUTICALS PLC, an Irish public limited company (“Parent”), PLEX MERGER SUB, INC., a Delaware corporation (“Merger Sub”) and an indirect wholly owned subsidiary of Parent, and Celator Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER dated as of April 28, 2016, among COMCAST CORPORATION, COMCAST PARIS NEWCO, INC. and DREAMWORKS ANIMATION SKG, INC.Agreement and Plan of Merger • April 28th, 2016 • DreamWorks Animation SKG, Inc. • Services-motion picture & video tape production • Delaware
AGREEMENT AND PLAN OF MERGER dated as of April 28, 2016 (this “Agreement”), among Comcast Corporation, a Pennsylvania corporation (“Parent”), Comcast Paris NewCo, Inc., a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Parent, and DreamWorks Animation SKG, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER dated as of April 25, 2015, among CAP GEMINI S.A., CAPGEMINI NORTH AMERICA, INC., LAPORTE MERGER SUB, INC. and IGATE CORPORATIONAgreement and Plan of Merger • April 27th, 2015 • Igate Corp • Services-computer programming services • Pennsylvania
WHEREAS, the Company has entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of April 25, 2015, 2015, by and among the Company, Cap Gemini S.A., a French societe anonyme (“SA”), Capgemini North America, Inc., a Delaware corporation (“NA” and, together with SA, “Parent”), Laporte Merger Sub, Inc., a Pennsylvania corporation (“Merger Sub”) and a wholly owned subsidiary of NA, a copy of which has been provided to the Shareholders and is attached hereto as Exhibit A (capitalized terms used herein without definition shall have the respective meanings ascribed to them in the Merger Agreement);
